创建量化系统的路线图 药理学信息的罕见疾病药物开发:研讨会报告
Jane P F Bai1, Audra L Stinchcomb2, Jie Wang1
1Office of Clinical Pharmacology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
这次研讨会探讨了定量系统药理学 (QSP),以推进罕见病药物开发. 提出了关键发现和路线图,以整合QSP工具以加速治疗.
科学领域:
- 监管科学 监管科学
- 翻译医学是一种翻译医学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 加速罕见疾病治愈 (ARC) 计划旨在开发用于罕见疾病药物开发的监管和科学工具.
- 工具包括药物/疾病建模,剂量选择和转化医学.
研究的目的:
- 讨论定量系统药理 (QSP) 在罕见疾病药物开发中的实用性.
- 确定QSP实施的挑战和解决方案.
- 为QSP提供信息的罕见病药物开发提出路线图.
主要方法:
- 美国食品和药物管理局和马里兰大学监管科学与创新卓越中心 (M-CERSI) 主办了一场虚拟公共研讨会.
- 参与者包括来自制药公司,学术界和FDA的科学家.
- 讨论的重点是QSP在罕见病药物开发中的潜力和挑战.
主要成果:
- 研讨会确定了QSP在罕见疾病药物开发中的潜在实用性.
- 讨论了QSP整合的关键挑战和潜在解决方案.
- 报告了研讨会的主要发现和关键的收获.
结论:
- QSP具有显著的潜力,可以帮助罕见疾病药物开发.
- 提出了一份路线图,以促进在该领域使用QSP.
- 监管机构,行业和学术界之间的合作至关重要.
更多相关视频
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
08:47Experimental Quantification of Interactions Between Drug Delivery Systems and Cells In Vitro: A Guide for Preclinical Nanomedicine Evaluation
Published on: September 28, 2022
相关概念视频
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Drug Discovery: Overview
Analysis of Population Pharmacokinetic Data
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
